Arcellx

Medical Science Liaison (Florida)

Remote

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Medical Science Liaison (MSL)

Employment Type: [Not Specified] Location Type: [Not Specified] Salary: [Not Specified]


Who We Are

Arcellx is a public, clinical-stage biotechnology company dedicated to reimagining cell therapy. We engineer innovative immunotherapies for patients suffering from cancer and other incurable diseases. We firmly believe that cell therapies represent a significant advancement in medicine, and our mission is to eradicate cancer and improve human lives by developing cell therapies that are safer, more effective, and broadly accessible.

Our team comprises exceptional innovators and visionaries operating from our offices in Rockville, Maryland, and Redwood City, California. At Arcellx, we attract outstanding talent and cultivate a dynamic, inclusive, supportive, and informal work environment where everyone can thrive and achieve their best.


What Matters to Us

Living our core values is fundamental to fostering a high-performing, inclusive, and collaborative work environment. We seek candidates who demonstrate strong alignment with our values and contribute diverse backgrounds, perspectives, and skills to our team.

Arcellx Core Values:

  • Start with authenticity: We cultivate an inclusive environment where every individual can bring their authentic self to work.
  • Think ‘we’ before ‘me’: We prioritize collective success, fostering collaboration and mutual support to achieve our shared objectives.
  • Embrace the challenge: We deliver exceptional results through shared determination and an unwavering commitment to doing what is right.

How You’ll Make a Difference

As a Medical Science Liaison (MSL), you will be an integral part of our field-based medical team, reporting directly to the MSL National Field Director. You will act as an extension of the Medical Affairs team, serving as a crucial scientific resource and expert in cell therapy for both healthcare professionals (HCPs) and internal stakeholders. By cultivating relationships with thought leaders and HCPs, engaging in external-facing medical education, and collecting insights through fair and balanced scientific exchange, you will play a pivotal role in the success of our transformative therapy.


The “Fine Print” – What You’ll Do

  • Establish and maintain professional relationships with HCPs (MD, PA, NP, RN, PharmD) within the hematology space through both in-person and virtual interactions.
  • Develop and execute territory plans that align with Medical Affairs strategies, including engaging with community thought leaders, disease state experts, cell therapy-referring HCPs, and academic centers.
  • Compliantly partner with field-based teams to optimize HCP support and customer service.
  • Deliver approved medical and scientific education relevant to the disease state and Arcellx products.
  • Share insights gathered from external thought leaders and HCPs to inform the development of medical strategies and future clinical programs.
  • Represent Arcellx at medical and scientific conferences.
  • Partner with clinical operations to support the execution of clinical trials.
  • Domestic travel of approximately 50-70% will be required.

Skills and Experience We Look For

  • An advanced degree in health sciences (PharmD, M.D., or Ph.D. in a medically related field) with a minimum of 2 years of relevant experience in the hematologic malignancy therapeutic area and/or cell therapy is preferred. A Master’s degree in health sciences (RN, RPh, PA, NP, etc.) will be considered if accompanied by extensive years of clinical and/or medical affairs experience in the relevant therapeutic area.
  • A minimum of 2 years of experience as an MSL or in Medical Affairs within a relevant therapeutic area. Experienced candidates may be considered for a senior-level position.
  • Familiarity and/or experience with healthcare systems and access environments.
  • Demonstrated ability to partner, influence, and work successfully within and across functions and leadership levels.
  • Excellent communication and presentation skills, coupled with strong personal integrity.
  • Agile, adaptable, and results-oriented.
  • Must reside within the designated territory.

Rewards at Arcellx

Our people are our greatest asset, and we are committed to supporting their well-being.

Skills

Cell Therapy
Medical Affairs
Scientific Exchange
Medical Education
Thought Leader Engagement
Insight Collection

Arcellx

Develops immunotherapies for cell therapy

About Arcellx

Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that enhance the effectiveness of treatments. The company collaborates with healthcare providers and research institutions to bring these therapies to patients. Unlike many competitors, Arcellx emphasizes proprietary products and partnerships to drive their research and development efforts. The goal is to meet unmet medical needs by providing safe and effective treatment options through their innovative approach to cell therapy.

Gaithersburg, MarylandHeadquarters
2014Year Founded
$194.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Unlimited Paid Time Off
Flexible Work Hours
401(k) Company Match
Fully-Paid Parental Leave
Tuition Reimbursement
Relocation Assistance

Risks

Competition from established CAR-T therapies like Abecma and Carvykti could limit market share.
Dependency on Gilead's Kite partnership poses risks if partnership dynamics change.
Phase 3 iMMagine-3 trial delays or failures could impact anito-cel's market timeline.

Differentiation

Arcellx's CART-ddBCMA has FDA Fast Track and Orphan Drug designations.
The novel D-Domain binder in anito-cel enhances antigen binding and cell killing.
ARC-SparX offers dosable and controllable CAR-T therapy options.

Upsides

Growing investment in personalized medicine aligns with Arcellx's tailored immunotherapies.
Advancements in gene editing like CRISPR enhance precision in engineered cell therapies.
Outpatient CAR-T administration could reduce costs and increase accessibility for Arcellx.

Land your dream remote job 3x faster with AI